Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug linvoseltamab takes on multiple myeloma in early trial

NCT ID NCT05828511

Recruiting now Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called linvoseltamab in people newly diagnosed with multiple myeloma, a type of blood cancer. The drug is designed to help the immune system attack cancer cells. The trial will check for side effects and see if the drug can shrink tumors. About 149 participants will take part, some before and after a stem cell transplant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

linvoseltamab (a bispecific antibody that targets BCMA on myeloma cells and CD3 on immune cells)

What this could lead to

If successful, this could provide a new treatment option for newly diagnosed multiple myeloma, potentially improving response rates and depth of remission.

What could go wrong

This is an early-phase trial (Phase 1/2) with a small number of participants, so safety and effectiveness are not yet proven. Side effects, including immune reactions, are possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU De Lille

    NOT_YET_RECRUITING

    Lille, 59000, France

  • Centre Hospitalier Universitaire (CHU) Montpellier

    RECRUITING

    Montpellier, 342950, France

  • Centre Hospitalier Universitaire (CHU) de Poitiers

    RECRUITING

    Poitiers, Vienne, 86021, France

  • Clinica Universidad de Navarra

    RECRUITING

    Pamplona, Navarre, 31008, Spain

  • Clinica Universidad de Navarra - Madrid

    RECRUITING

    Madrid, 28027, Spain

  • Colorado Blood Cancer Institute/SCRI

    RECRUITING

    Denver, Colorado, 80218, United States

  • Columbia University _ New York Presbyterian

    RECRUITING

    New York, New York, 10032, United States

  • Duke University Health System (DUHS)

    RECRUITING

    Durham, North Carolina, 27705, United States

  • Gustave Roussy

    RECRUITING

    Villejuif, Île-de-France Region, 94800, France

  • Hopital Necker

    RECRUITING

    Paris, Île-de-France Region, 75015, France

  • Hopital Prive d'Antony

    RECRUITING

    Antony, Île-de-France Region, 92160, France

  • Hopital Saint Louis

    RECRUITING

    Paris, 75010, France

  • Hospital Clinic de Barcelona

    RECRUITING

    Barcelona, 08036, Spain

  • Hospital General Universitario Doctor Balmis Alicante

    RECRUITING

    Alicante, Valencia, 03010, Spain

  • Hospital Germans Trias i Pujol

    RECRUITING

    Badalona, Barcelona, 08916, Spain

  • Hospital Universitari i Politecnic La Fe

    RECRUITING

    Valencia, 46026, Spain

  • Hospital Universitario Central de Asturias

    RECRUITING

    Oviedo, Principality of Asturias, 33011, Spain

  • Hospital Universitario Quiron Salud Madrid

    RECRUITING

    Pozuelo de Alarcón, Madrid, 28223, Spain

  • Hospital Universitario de Salamanca

    RECRUITING

    Salamanca, 37007, Spain

  • Institut Catala dOncologia (ICO Hospitalet)

    RECRUITING

    Barcelona, 08908, Spain

  • Karmanos Cancer Institute

    RECRUITING

    Detroit, Michigan, 48201, United States

  • Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

  • Norton Cancer Institute

    RECRUITING

    Louisville, Kentucky, 40207, United States

  • Perlmutter Cancer Center

    RECRUITING

    New York, New York, 10016, United States

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island

    RECRUITING

    Mineola, New York, 11501, United States

  • Rutgers Cancer Institute of New Jersey

    RECRUITING

    New Brunswick, New Jersey, 08901, United States

  • Stony Brook University Hospital

    RECRUITING

    Stony Brook, New York, 11794, United States

  • The University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • UC Irvine Health

    RECRUITING

    Orange, California, 92868, United States

  • Universitary Hospital La Princesa

    RECRUITING

    Madrid, 28006, Spain

  • University Hospitals Pitie Salpetriere - Charles Foix

    RECRUITING

    Paris, 75651, France

  • University of California Los Angeles (UCLA)

    RECRUITING

    Los Angeles, California, 90095, United States